The therapeutic peptides used in surgical recovery are synthetic versions of molecules the body already makes, manufactured under cGMP pharmaceutical conditions, purified to a single active species, and dosed precisely
Not evaluated by the FDA.
Liraglutide is a GLP-1 receptor agonist that regulates appetite, slows gastric emptying, and enhances insulin secretion in response to meals, aiding in weight management and blood glucose control
Benefits of Compounded Semaglutide with L-Carnitine Patients may experience: Reduced appetite and cravings Feeling fuller for longer Slower gastric emptying for better portion control Improved fat metabolism and energy from L-Carnitine Better exercise endurance and weight-loss results Lower blood sugar and support for type 2 diabetes management Reduced risk of heart disease and weight-related conditions A safe, long-term weight loss solution Support for patients with difficult-to-treat conditions like PCOS Ongoing monitoring from Seattle Plastic Surgery providers (in-person or virtual) Possible Side Effects Semaglutide is generally well-tolerated, and most side effects improve within the first two weeks
[3] Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL
no direct serotonergic activity documented QTc consideration / both agents carry independent QTc signals